Ascletis Pharma Inc.

Investors

Next Day Disclosure Returns - Share Buyback
2026-06-03
Next Day Disclosure Returns - Share Buyback
2026-06-02
Proposed Amendments to the Articles of Association and Adoption of the Third Amended and Restated Memorandum and Articles of Association
2026-06-02
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
2026-06-01
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026
2026-05-07
Voluntary Announcement - Ascletis to Present Data on Multiple Programs at the 33rd European Congress on Obesity (ECO 2026)
2026-05-06
Voluntary Announcement - Ascletis to Present Data on Multiple Programs at the American Diabetes Association’s 2026 Scientific Sessions
2026-04-30
Annual Report 2025
2026-04-29
Voluntary Announcement - Ascletis Completes Enrollment in U.S. Phase II Study of ASC30, an Oral Small Molecule GLP-1R Agonist, for the Treatment of Diabetes
2026-04-27
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026
2026-04-08

4

© 2018 Ascletis Pharma Inc. All Rights Reserved
浙公网安备 33010802003344号浙ICP备11050387号-1